ASCENEURON
Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimerโs disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases. Tauopathies are currently untreatable neurodegenerative diseases that rapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in... neurons of the brain is a common feature of tauopathies that is shared with Alzheimerโs disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Due to increasing life expectancy, Alzheimerโs disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
ASCENEURON
Social Links:
Industry:
Biotechnology Health Care Therapeutics
Founded:
2012-01-01
Address:
Lausanne, Vaud, Switzerland
Country:
Switzerland
Website Url:
http://www.asceneuron.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
30.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Content Delivery Network Domain Not Resolving Apache Euro
Similar Organizations
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Advisors List
Current Employees Featured
Founder
Investors List
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Asceneuron
Michael J. Fox Foundation
Michael J. Fox Foundation investment in Grant - Asceneuron
Johnson & Johnson Innovation
Johnson & Johnson Innovation investment in Series A - Asceneuron
SR One
SR One investment in Series A - Asceneuron
Sofinnova Partners
Sofinnova Partners investment in Series A - Asceneuron
M Ventures
M Ventures investment in Series A - Asceneuron
Kurma Partners
Kurma Partners investment in Series A - Asceneuron
Official Site Inspections
http://www.asceneuron.com Semrush global rank: 8.65 M Semrush visits lastest month: 274
- Host name: qx2.tophost.ch
- IP address: 194.150.248.33
- Location: Switzerland
- Latitude: 47.1449
- Longitude: 8.1551
- Timezone: Europe/Zurich